HIMS Stock Overview
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HIMS from our risk checks.
My Notes
NewNotes are coming soon
Hims & Hers Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.84 |
| 52 Week High | US$8.54 |
| 52 Week Low | US$2.72 |
| Beta | 0.58 |
| 1 Month Change | 27.90% |
| 3 Month Change | 42.03% |
| 1 Year Change | 68.24% |
| 3 Year Change | -21.68% |
| 5 Year Change | n/a |
| Change since IPO | -20.00% |
Recent News & Updates
Hims & Hers: Profitability Pulled Forward
Jan 25Hims & Hers Health: Buy Into The Strong Growth Momentum
Jan 18Recent updates
Hims & Hers: Profitability Pulled Forward
Jan 25Hims & Hers Health: Buy Into The Strong Growth Momentum
Jan 18Devon Energy And Hims & Hers Health - Raul Shah's Hot Take
Jan 05Hims & Hers Health: The Ultimate Pick For 2023
Dec 23Hims & Hers Health: The Unicorn (Former) SPAC For 2023
Dec 17Hims & Hers Health Seems Like A Great Pick For 2023
Dec 10Party Time: Brokers Just Made Major Increases To Their Hims & Hers Health, Inc. (NYSE:HIMS) Earnings Forecasts
Nov 12
Him & Hers Health jumps 16% after hours as 2022 revenue guidance well above consensus
Nov 07Hims & Hers: The Market Has Lost Its Mind
Oct 21An Intrinsic Calculation For Hims & Hers Health, Inc. (NYSE:HIMS) Suggests It's 34% Undervalued
Sep 20Hims & Hers: Just What The Doctor Ordered
Sep 16Hims & Hers: Here's A Prescription For Portfolio Dysfunction
Aug 20Hims & Hers Health: Promising Return Profile
Jul 17Hims & Hers Health: Undervalued Company With Tremendous Upside
Jun 12Hims & Hers: Improving Fundamentals + Declining Price = A Generational Buy
May 16Hims & Hers: Q1 Earnings Impresses Investors, Hugely Increases Guidance
May 10Hims & Hers Health: A No-Brainer
Mar 17Hims & Hers: Healthy Portfolio Subscription
Feb 23HIMS: Great Buying Opportunity
Feb 08Hims & Hers: Massively Undervalued Compared With Ro
Dec 20Hims & Hers Health: The Valuation Article
Dec 09Hims & Hers: Great Business, Greater Opportunity
Nov 30Hims & Hers Health Stock: An Opportunity After Large Sell-Off
Oct 06Hims & Hers Health: An Amazing Bargain Price For This High Growth Stock
Sep 23Time To Buy Hims & Hers
Aug 25Hims & Hers Stock: Trading At All-Time Lows, Worth Considering A Buy
Aug 18New Forecasts: Here's What Analysts Think The Future Holds For Hims & Hers Health, Inc. (NYSE:HIMS)
Aug 17Hims & Hers: Collapse Comes With Risks And Opportunities For Its Investors
Aug 07Hims & Hers to acquire London-based Honest Health
Jun 14Hims & Hers: Riding The DTC Telehealth Wave
Jun 04Earnings Release: Here's Why Analysts Cut Their Hims & Hers Health, Inc. (NYSE:HIMS) Price Target To US$15.50
May 20Shareholder Returns
| HIMS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.3% | -4.4% | 0.9% |
| 1Y | 68.2% | -7.2% | -10.9% |
Return vs Industry: HIMS exceeded the US Healthcare industry which returned -4.6% over the past year.
Return vs Market: HIMS exceeded the US Market which returned -9.6% over the past year.
Price Volatility
| HIMS volatility | |
|---|---|
| HIMS Average Weekly Movement | 10.2% |
| Healthcare Industry Average Movement | 7.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: HIMS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: HIMS's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 398 | Andrew Dudum | https://www.forhims.com |
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.
Hims & Hers Health, Inc. Fundamentals Summary
| HIMS fundamental statistics | |
|---|---|
| Market Cap | US$1.63b |
| Earnings (TTM) | -US$85.93m |
| Revenue (TTM) | US$444.41m |
3.7x
P/S Ratio-19.0x
P/E RatioIs HIMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIMS income statement (TTM) | |
|---|---|
| Revenue | US$444.41m |
| Cost of Revenue | US$105.93m |
| Gross Profit | US$338.48m |
| Other Expenses | US$424.42m |
| Earnings | -US$85.93m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 76.16% |
| Net Profit Margin | -19.34% |
| Debt/Equity Ratio | 0% |
How did HIMS perform over the long term?
See historical performance and comparison